Kami laporkan satu kasus sarcoma Ewing pada ibu jari kaki kiri dengan trans-artikular skip-lesion pada diafisis tulang tibia kiri. Dalam periode 1995Dalam periode -2004 
Ewing sarcoma is a highly malignant primary neoplasm of bone that often metastasizes to other sites, including other bones, by the time the patient is first seen by a physician. The frequency in the United States depends on the patient's age. Tumor occurrence ranges from 0.3 case per 1,000,000 children younger than 3 years to as high as 4.6 cases per 1,000,000 adolescents aged 15-19 years. Internationally the annual incidence rate averages less than 2 cases per 1,000,000 children. 3 In Cipto Mangunkusomo Hospital since 1995 until 2004 we have found 20 (20 of 118 malignancy in bone in children) Ewing sarcoma cases. But we only found one skip lesion case of Ewing sarcoma. We report a rare case of Ewing sarcoma of the left big toe in association with transarticular skip lesion on the left diaphysis of tibia and proximal femur.
CASE PRESENTATION
A sixteen-year old man presented with the lump on his left big toe growing since three months before admission. The lump at that site accompanied by ulceration starting to appear one month ago. It began when he clipped his toe nails. He was brought immediately to a general hospital and had a Rosser plasty. However, it worsen after surgery characterized by getting bigger and more painful. Foul smell came out from it. By then, he was brought to Pasar Rebo Hospital. Plain X-Ray was performed and he was suggested for amputation by orthopedic surgeon. But the family refused, and therefore the doctor referred him to Ciptomangunkusumo Hospital.
Figure 1. Tumor at the left big toe with ulceration and nectic tissue
It was found that in addition to the lump on the toe, he also had another growing lump which was located on his left leg. This lump occurred at the same time as the lump on his toe, but smaller in size.
We found on his toe ulcerated mass, pus, and necrotic tissue. The mass was 11 x 10 x 8 cm in size, and 30 cm circumferential in length with soft consistence, well defined margin (Fig.1) , actively bleed, and tender. In the mid part of left leg, there was painless mass, 8 cm in diameter, no vein dilatation, no ulceration, firm in consistence, and ill defined margin (Fig.2) .
Laboratory findings
The laboratory findings showed ESR 75 mm/h (0,0 -10,0 mm/h), serum alkaline phosphatase 297 µ/dl (35-187), CRP 36,8 µ/dl (0,0-05,0) and lactic dehydrogenase 234 µ/dl (100-190).
Imaging findings
Left foot AP and lateral Plain X rays showed destruction of the distal phalanx of left big toe and soft tissue mass. (Fig.3 ) On the left leg plain X rays AP and lateral views showed permeative lytic destruction of shaft of the tibia and also periosteal reaction. (Fig.4) Bone scintigraphy showed increased activity in the left foot, mid-shaft of the tibia, proximal tibia and proximal femur (Fig.5) . The patient was admitted to the hospital and underwent a fine needle biopsy and also discussed in the Clinico Pathological Conference (CPC).
Fine Needle Aspiration Biopsy (FNAB) specimen was obtained from the mass at foot. The result was small round cells sarcoma, preferred PNET/Ewing sarcoma (Fig.6 ). In CPC, patient was diagnosed as Ewing sarcoma of the left big toe with suspicious trans-articular skip lesion on the left mid-diaphysis of tibia. We also concluded that increased activity in proximal tibia and also proximal femur as inflammatory process. We decided to do ray amputation for left big toe and open biopsy of mass on the left mid-diaphysis of tibia to confirm diagnosis.
Macroscopically, speciment from ray amputation showed tan-grey mass, haemorrhagic and necrotic tissue and also pus. (Fig.7a-b) . Grossly, open biopsy specimen of left mid diaphysis mass showed tumor mass with yellowish white appeareance and semi fluid tissue. Histopathological findings of both specimens showed small round cells with round nuclei containing fine cromatin with eosinophilic cytoplasms (Fig.8a-c) . Induction chemotherapy consisted of vincristine, actinomycin D, ifosfamide, and adriamycin (VAIA) 7 cycles was administered.
After four cycles induction chemotherapy, the tumor mass at the leg enlarged and lymphnodes enlargement in the inguinal region were found, thus confirming inefficiency of the chemotherapy (Fig.9) .
Figure 9. Showed clinical picture after 4 cyles chemotherapy
Therefore, the patient was scheduled for limb ablation surgery-above knee amputation and incisional biopsy of lymphnodes in the inguinal region followed by three cycles adjuvant chemotherapy. Nine months after diagnosis, distance metastases were detected at the craniofascial region and humerus. And one month later, the pasient was dead due to cerebral metastasis.
DISCUSSION
Ewing's sarcoma is a highly malignant tumor that is a type of peripheral primitive neuroectodermal tumor (PNET). Ewing's sarcoma is found in the lower extremity more than in the upper extremity, but any long tubular bone may be affected. The most common sites are the metaphysis and diaphysis of the femur followed by the tibia and humerus.
1,2 The tumor is derived from red bone marrow. Most frequently, it is observed in children and adolescents aged 4-15 years and rarely develops in adults older than 30 years. Ewing sarcoma accounts for approximately 5% of biopsyanalyzed bone tumors and approximately one third of primary bone tumors. It is the second most common malignant bone tumor in young patients. 3, 4 Males are affected more frequently than females, with a ratio of approximately 1.5:1. 4 Ewing Sarcoma on the left big toe is a very rare case. Never is transarticular skip lesion in association with Ewing sarcoma reported before in our institution, and perhaps in Indonesia. In 1989, Sundaram et al reported a case of skip lession Ewing sarcoma at the femur. 4, 5 The term skip lesion has been used to describe a separate focus of osteosarcoma that developed synchronously in the same bone as another osteosarcoma, in the absence of direct anatomical extension between the lesions or of metastases. 1, 4 Others have verified the development of skip osteosarcomas, although there has been disagreement about their frequency.
In our patient, the transarticular skip lesion of Ewing sarcoma may have been missed at the first CPC. The lesion in the proximal tibia and proximal femur where considered as inflammatory process because of very rare case. But both radiography and bone scintigraphy examination indicated that the midshaft of tibia lesion was a skip lesion. These were supported by histopathological results that confirmed were Ewing sarcoma.
The European Intergroup Cooperative Ewing's Sarcoma Study (EICESS) included 369 patients treated with local therapy and chemotherapy based on 14 courses of vincristine, actinomycin D, cyclophosphamide or ifosfamide, and Adriamycin with or without etoposide. The 3-year event-free survival rate was 66% in patients with localized tumors, 43% in those with lung metastases at initial diagnosis, and 29% in those with other metastases.
1
The inclusion of resection in the protocol for the treatment of Ewing sarcoma provides an opportunity to examine the effect of preoperative chemotherapy on the primary tumor. In patients who have osteosarcoma, a tumor that usually is treated with preoperative chemotherapy, chemotherapy-induced tumor necrosis facilitates operative resection and the extent of the necrosis is a major prognostic indicator of both local and systemic recurrence.
6 Jürgens et al. as well as Picci et al. suggested that the histological response to preoperative chemotherapy may also be an important indicator of the systemic outcome for patients who have Ewing sarcoma. Verril et al mentioned that a large tumor volume was negative prognostic factors.
5,7
Approximately 19 per cent of patients who have Ewing sarcoma have metastatic disease when they are first seen, which indicates a very poor prognosis. 5 Wunder JS et al. have found that chemotherapy-induced tumor necrosis is also the most important indicator of event-free survival for patients who have had operative treatment of Ewing sarcoma.
6
A lesser extent of tumor necrosis following chemotherapy was associated with an increased risk of systemic recurrence.
Similar findings have been reported in association with osteosarcoma.
7 Whereas some tumors respond rapidly, less responsive tumors, which are associated with a poor outcome, require an increased amount of chemotherapy to achieve an adequate clinical response before resection. Indeed, the clinical response to initial chemotherapy has been associated with the outcome in patients who have Ewing sarcoma, although it has been less predictive than the histological response.
7
Ewing Sarcoma on the left big toe with transarticular skip lesion is extremly rare case. The diagnosis of transarticular skip lesion in association of Ewing sarcoma was confirmed in clinicopathological conference. The patient who has Ewing sarcoma has metastatic disease when he is first seen, which indicates a very poor prognosis.
